SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-125560
Filing Date
2019-04-29
Accepted
2019-04-29 16:59:08
Documents
23
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F d734372d20f.htm 20-F 2339233
2 EX-4.7 d734372dex47.htm EX-4.7 83204
3 EX-4.13.1 d734372dex4131.htm EX-4.13.1 331949
4 EX-4.17.1 d734372dex4171.htm EX-4.17.1 8765
5 EX-4.19 d734372dex419.htm EX-4.19 89390
6 EX-8.1 d734372dex81.htm EX-8.1 4669
7 EX-12.1 d734372dex121.htm EX-12.1 10444
8 EX-12.2 d734372dex122.htm EX-12.2 10419
9 EX-13.1 d734372dex131.htm EX-13.1 3317
10 EX-13.2 d734372dex132.htm EX-13.2 3174
11 GRAPHIC g734372g0425234747941.jpg GRAPHIC 11512
12 GRAPHIC g734372g0425234748169.jpg GRAPHIC 20203
13 GRAPHIC g734372g0425234748637.jpg GRAPHIC 12238
14 GRAPHIC g734372g0425234748902.jpg GRAPHIC 12011
15 GRAPHIC g734372g0425234749144.jpg GRAPHIC 16931
16 GRAPHIC g734372g0425234749472.jpg GRAPHIC 18915
17 GRAPHIC g734372g0425234751248.jpg GRAPHIC 18677
18 GRAPHIC g734372g0425234751607.jpg GRAPHIC 13522
19 GRAPHIC g734372g0425234751957.jpg GRAPHIC 12737
20 GRAPHIC g734372g0425234752380.jpg GRAPHIC 12981
21 GRAPHIC g734372g61j18.jpg GRAPHIC 130057
22 GRAPHIC g734372i2.jpg GRAPHIC 33492
23 GRAPHIC g734372im1.jpg GRAPHIC 65368
  Complete submission text file 0001193125-19-125560.txt   3408994
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38452 | Film No.: 19776813
SIC: 2834 Pharmaceutical Preparations